In a recent decision of Düsseldorf Local Division (UPC) in the case UPC_CFI_505/2024, both the revocation and infringement actions have been dismissed. This case raises important methodologies and perspectives regarding how to handle infringement of second medical use claims where allegedly infringing product is launched with a therapeutical indication (Section 4.1 of SmPC) not falling...
